A class action lawsuit was filed against Cassava Sciences Inc. (SAVA) by Levi & Korsinsky on December 12, 2024. The ...

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 ...

This page features the latest news about the Cassava Sciences stock. Cassava Sciences to Resume Trading at 8 a.m. Cassava Sciences (NASDAQ:SAVA) to Resume Trading at 8 a.m.Cassava Sciences, ...

After hours: February 14 at 7:58:26 PM EST Loading Chart for SAVA ...

Based on 3 Wall Street analysts offering 12 month price targets forCassava Sciences Inc - Dist in the last 3 months.

(美国商业资讯)-- 全球投资者权益律师事务所Rosen Law Firm提醒投资者，一名股东代表所有在2024年2月7日至2024年11月24日期间购买Cassava Sciences, Inc.（NASDAQ: SAVA）证券的投资者提起集体诉讼 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you suffered a loss on your Cassava Sciences, Inc. (NASDAQ:SAVA) investment and want to learn about a potential ...

07, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company focused on Simufilam did not show a significant ...